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Inhibition of hepatocyte growth factor-induced motility and in vitro
invasion of human colon cancer cells by gamma-linolenic acid
WG Jiang', S Hiscoxl, MB Hallett', C Scott2, DF Horrobin2 and MCA Puntis'
'Department ofSurgery, University of Wales College ofMedicine, CardiffCF4 4XN, UK; 2Scotia Pharmaceuticals Ltd, Guildford,
UK.
Summary In this study we have determined the effects of the n-6 essential fatty acid gamma-linolenic acid
(GLA) on the motility and invasive/metastatic nature of the human colon cancer cell lines HT115, HT29 and
HRT18. Cell motility was induced by hepatocyte growth factor/scatter factor (HGF/SF) and measured by
both colony scattering and dissociation from carrier beads. Invasiveness was measured in vitro by cellular
invasion into extracellular matrix. At concentrations up to 100tM (which had no effect on cell growth over the
duration of the experiments) both cell motility and invasion induced by HGF/SF were markedly reduced by
GLA and its lithium salt. The attachment of these cells to the extracellular matrix components (Matrigel and
fibronectin) was also inhibited. There were also changes in the cell-surface E-cadherin, but not fibronectin
receptor at similar concentrations. It is concluded that n-6 essential fatty acids have the ability to inhibit both
motility and invasiveness of human colon cancer cells, perhaps by modifying cell-surface adhesion
molecules.
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n-6 polyunsaturated fatty acids are essential fatty acids which
cannot be synthesised in the human body. In recent years, a
number of workers have reported that these fatty acids have
anti-cancer growth or anti-proliferation properties. n-6 fatty
acids have been shown to have an effect on several cancer
cell types, including lung, breast, prostate, pancreatic cancer
and hepatoma cells (Begin et al., 1986, 1988; Botha et al.,
1989; Newman, 1990; Rose et al., 1991; Tiwari et al., 1991;
Hayashi et al., 1992; Takeda et al., 1992, 1993; Falconer et
al., 1994). Furthermore, the inhibition of tumour cell growth
by some cytokines is dependent on the presence of polyun-
saturated fatty acids (PUFAs) (Newman, 1990). Although
lipid peroxides have been postulated to be the main factors
responsible for n-6 fatty acid-induced cytotoxicity, some
metabolites of n-6 PUFAs have other biological activities.
For example, 13(s)-HODE (hydroxyoctadecadienoic acid)
inhibits tumour cell adhesion to endothelium, and thus may
reduce tumour metastasis, while another metabolite, 12(s)-
HETE (hydroxyeicosatetraenoic acid), stimulates adhesion
(Honn et al., 1992). In some but not all studies in both
humans and animals bearing breast or liver tumours, n-6
PUFAs have been shown to have beneficial effects (Karmali
et al., 1985; Ramchurren et al., 1985; McIllmurray and
Turkie, 1987; Van der Merwe et al., 1988, 1990; Prichard and
Mansel, 1990).
Key events in the formation of cancer metastases are cell
motility and invasion (Liotta, 1987; Schiffmann, 1990).
Various factors which promote motility have been implicated
in the process of invasion and metastasis. One such factor is
hepatocyte growth factor (HGF), otherwise known as scatter
factor (SF). This factor has been recognised as a potent
stimulus for tumour cell motility and invasion and its recep-
tor is encoded by the c-met proto-oncogene. There is much
interest in trying to understand the mechanisms of cell
motility. Effective cancer treatment may result from the
manipulation of the underlying intracellular signalling path-
ways involved in the control of motility.
Colon cancer is one of the most common tumours in
Western countries, and the more advanced tumours are
associated with a poor prognosis. Local invasion and
systemic metastasis are commonly seen in these patients, with
the liver being frequently involved (Donaldson and Welch,
1974; Eisenberg et al., 1982; August et al., 1984; Allen-
Mersh, 1989). Anti-metastatic strategies and agents could
therefore be of major importance in the treatment of such
cancer patients. Although in previous studies it has been
shown that linoleic acid may exert some effects on murine
colon cancer cells (stimulatory on growth at low concentra-
tion but inhibitory at higher concentrations; Hussey and
Tisdale, 1994), the effects of gamma-linolenic acid on human
cancer cells, particularly on motility and invasion, have not
been fully investigated.
In this paper, we report the inhibition of hepatocyte
growth factor/scatter factor (HGF/SF)-induced motility and
invasiveness of human colon cancer cells by the n-6 fatty acid
gamma-linolenic acid (GLA) and its clinically useful form,
the lithium salt (LiGLA). An attempt has also been made to
determine the possible mechanisms involved.
Materials and methods
The human colon cancer cell lines, HT115, HT29 and
HRT18, were obtained from ECACC (European Collection
of Animal Cell Cultures) and were maintained in Dulbecco's
modified Eagle medium (DMEM) containing 10% fetal calf
serum (FCS). Linoleic acid (LA), gamma-linolenic acid
(GLA), arachidonic acid (AA) and tocopherol were pur-
chased from Sigma and lithium gamma-linolenate was pro-
vided by Scotia Pharmaceuticals, Guildford, UK. Fatty acids
were initially dissolved in ethanol, stored in liquid nitrogen
and diluted in culture medium immediately before use
(ethanol final concentration <0.01%). Matrigel [extracted
from Engelbreth-Hom-Swarm (EHS) sarcoma] was pur-
chased from Collaborative Biochemical, Bedford, MA, USA,
Cytodex-2 carrier beads were obtained from Pharmacia,
fluorescein isothiocyanate (FITC)-labelled goat anti-mouse
IgG Ab2 was obtained from Sigma, anti-fibronectin receptor
and anti-E-cadherin monoclonal antibodies (HECD-1) were
from British Biotechnology and rabbit anti-mouse IgG was
from Dako.
Cell motility
Cell dissociation assay Our method was essentially the same
as that described by Rosen et al. (1990). Cells were cultured
with Cytodex-2 beads (5 mg ml-') for 24 h. The beads were
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then harvested and washed in culture medium. A small sam-
ple of this suspension was used to quantify total cell number
attached to the beads: cells were dissociated from the carrier
beads with hydrochloric acid, the nuclei stained with crystal
violet, and then counted with a haemocytometer. The cell
number in the original suspension was then adjusted to
5 x IO' cells ml-1. Aliquots of this suspension of beads with
attached cells were placed into 96-well multiplates (Nunc,
Denmark) and fatty acids were then added to the cells. After
24 h culture, the plates were emptied and washed with
balanced salt solution (BSS) buffer to remove all the carrier
beads. Cells which had detached from the beads and which
were attached to the bottom of the wells were fixed in
buffered formalin and counted after staining with 0.5% crys-
tal violet.
Colony scattering This method was essentially as described
by Gherardi et al. (1989). Colon cancer cells at iO0 cells ml-'
were incubated overnight in 24-well plates to allow colony
formation. Fatty acids were added and incubation continued
for a further 24 h, after which the plates were fixed, stained
with crystal violet and the colonies observed and photo-
graphed. In some of the experiments, anti-E-cadherin anti-
body was added to cells before colony formation in order to
determine the role of E-cadherin in colony formatic-n.
Cell invasion assay
This was based on the methods described by Albini et al.
(1987) and Parish et al. (1993). Briefly, transwell chambers
(Costar, Cambridge, MA, USA) were equipped with 6.5 mm-
diameter polycarbonate membranes (pore size = 8 jm) pre-
coated with a solubilised tissue basement membrane (Matrigel,
50pg per membrane). After rehydration of the membrane,
5 x 104 cells were added to each well with or without HGF/
SF (5 ng ml-'), which will promote invasion. After 72 h cul-
ture, the non-invasive cells and membrane were removed with
a cotton swab, and the cells which had migrated through the
membrane and stuck to the lower surface of the polycarbon-
ate membrane were fixed and stained with crystal violet.
After extraction with 10% acetic acid the absorbance was
measured at 540 nm with a Titertek multiscanner. The value
for an experimental culture is expressed as a ratio to the
control value which was obtained with culture medium only,
and this ratio is referred to as the invasion index.
Cell attachment assay
This was based on the method described recently (Furukawa
et al., 1993). Briefly, Matrigel (1 gIg per well) and,fibronectin
(1 glg per well) were added to multiwell plates, which were
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Figure 1 The effect of fatty acids on colony scattering induced by HGF/SF and the role of E-cadherin [HTlT15 cells (a-f) and
HRTI8 cells (g-l)]. (a and g) Control colonies. (b and h) Cells with HGF/SF (5 ngml'). (c and i) Cells with GLA 50 SOM and
HGF/SF (5 ngml-'). (d and j) Cells with GLA 50gM alone. (e and k) Cells with anti-E-cadherin antibody alone (0.5 yg ml-). (f
and 1) Cells with GLA (50gM), HSF/SF (5 ng ml- 1) and anti-E-cadherin antibody. The culture was for 24 h and cells stained with
crystal violet. Colonies ofHTl 15 cells are completely scattered by HGF/SF (b) and this scattering is significantly inhibited by GLA
(c). HGF/SF induces partial scattering of HRT18 colonies (h), and this scattering is also inhibited by GLA (i). HECD-1 antibody
caused marked loosening of colonies (e and k). GLA-reduced colony scattering which was stimulated by HGF/SF was completely
neutralised with HECD-1 (f and 1).
incubated for 24 h, to allow binding to the surface of the
well. The plates were then washed and bovine serum albumin
(BSA) (5% w/v) added to block remaining binding sites.
Cells (104 per well) were added with or without fatty acid for
30 min and unbound cells removed by aspiration. The
numbers of attached cells were measured by the 3-[4,5-di-
methylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT)
assay described below.
Cellgrowth
Growth was measured using a standard calorimetric MTT
assay (Tada et al., 1986). Cellular DNA contents were also
quantified with Hoechst 33258. Cells were seeded into 96-well
plates at 104 cells per well and the fatty acids were added;
tocopherol (10tsM) was also added to some wells. The plates
were incubated for up to 6 days, and at the end of. this
period cell numbers were determined using both methods. In
the MTT assay, the coloured crystals produced within the
cells were extracted with 10% Triton X-100 overnight and
absorbance measured at 540 nm. The cell growth was cal-
culated as percentage growth induced by fatty acids com-
pared with culture medium alone. In Hoechst assay, cells
were treated with 0.01% SDS for 60 min at the end of
culture and then Hoechst 33258 was added (final concentra-
tion = 1.0 ygml-'). DNA from calf thymus (Sigma Dl501)
was used as an internal standard. Fluorescence was measured
with a Multi-fluoroscanner (Wellfluor Denley, UK). DNA
contents are shown as relative fluorescent units.
Immunohistochemical study ofcell adhesion molecules
Cells were cultured with various fatty acids for 0.5, 1 or 20 h
in the presence of an antioxidant before fixation with 4%
formaldehyde. After blocking the endogenous peroxidase
with methanol (with 0.3% hydrogen peroxide), the non-
specific binding sites were blocked by BSA (4%, w/vj for
60 min. After washing with BSS, the primary antibody, eitherInhibitin ofInvasion andmotility byGLA
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Figure 2 Inhibition of HT115 cell dissociation from carrier beads by n-6 fatty acids. HT115 cells were cultured in the conditions
mentioned above. The cell numbers dissociated from carrier beads are shown as cells per high-power field. Only a weak effect was
seen in the controls (U). The motility that was increased by HGF/SF (5 ng ml-') (A) was significantly inhibited by GLA and
LiGLA. Linoleic acid (LA) showed weak inhibition. Arachidonic acid (AA) had no effects. Shown in the figure are means ± s.e.m.
(n = 5).
anti-fibronectin receptor or anti-E-cadherin diluted in BSS
containing BSA (1%, w/v), was added to the cells followed
by incubation for 60 min. Following extensive washing,
peroxidase-conjugated IgG was used as the detecting anti-
body and diaminobenzidine (DAB) as the colour-developing
agent. Slides were mounted with Sterilite mountant (BDH)
and observed under a light microscope.
Flow cytometry
Cold medium containing EDTA (0.05% in phosphate-buffer-
ed salinel was used in the collection of cells for antibody
binding studies: trypsin was omitted to avoid damage to
cell-surface molecules. Cells were incubated with the primary
antibody (1:500 dilution for both primary antibodies) for
20 min at 4°C, followed by FITC-labelled secondary antibody
(1:1000 dilution for 20min, 4C), before fixing with parafor-
maldehyde (4%). Flow cytometric fluorescence was measured
using a FACScan (Becton Dickinson).
Results
Effect ofFAs on cell motility; attachment and invasion
The n-6 fatty acid GLA inhibited HGF/SF-induced colon
cancer cell colony scattering (as reported previously; Jiang et
al., 1993) (Figure 1 a-f for HTI15, g-l for HRT18 cells). In
addition, dissociation of cells from Cytodex-2 beads was also
inhibited in a concentration-dependent manner by gamma-
linolenic acid (Figure 2). A similar inhibition of motility as
measured by Cytodex-2 dissociation was also seen with the
water-soluble lithium salt of GLA (LiGLA). GLA also inhi-
bited cell dissociation in the absence of HGF/SF, although
the inhibitory effect on HGF/SF-induced dissociation was
more profound. Linoleic acid (LA), the parent form ofGLA,
only weakly inhibited motility, while arachidonic acid (AA)
had no effect (Figure 2). The other cell types tested were
found to have slightly different sensitivities to GLA, HT115
cells being the most sensitive tested and HT29 the least
sensitive. The decrease in the number of cells detached from
carrier beads and attached to the plastic surface could not be
attributed to the effects of fatty acids on cell attachment to
plastic, since the plating efficiency was unaffected by the
presence of fatty acids over the range of concentrations
tested in this study. The data shown are from HT115 cells, in
which- GLA and LiGLA showed profound effects, LA
showed weak inhibition and AA had no effect.
Attachment of these cells to Matrigel and fibronectin was
also diminished by n-6 fatty acids, GLA and LiGLA inhibit-
ing the attachment to both matrices, while LA had a much
weaker effect. AA had no significant effects on attachment in
this study. The responses of HTI15 cells are shown in Figure
3. All three cell types showed a similar response to these fatty
acids. Inclusion of tocopherol in the assay had no effect on
the inhibition by GLA and LiGLA.
GLA also significantly inhibited HGF/SF-stimulated in
vitro invasion of the tumour cell lines HT115 and HRT18
cells through basement membranes. HGF/SF significantly
promoted tumour cell invasion into Matrigel. This was
significantly inhibited by both forms of GLA. LA also
exerted slight inhibition, while AA had no effect. GLA and
LiGLA alone had a small but insignificant inhibitory effect
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Figure 4 Effects of GLA on the invasion of colon cancer cells.
Data are shown for HRT18 migrating through Matrigel-coated
membrane in both control ( ) and one induced by HGF/SF
( M ). The invasiveness was significantly promoted by HGF/SF.
Two forms of GLA significantly inhibited invasion induced by
HGF. LA showed a much lesser inhibition and AA had no
effects. Fatty acid alone had negligible effects on the migration.
(means ± s.e.m., n = 3).
on invasiveness. Representative responses from HRT18 cells
are shown in Figure 4.
The contribution ofcellgrowth to the effects seen
In order to examine the possibility that the inhibition of cell
growth by fatty acids contributed to the observed reduced
motility, cell growth was determined. None of the fatty acids
tested affected cell growth after 1 or 2 days in culture, and
only very limited inhibition was seen with GLA and LiGLA
(<10%) at concentrations over 100 1M. LA and AA had
negligible effects. This was confirmed in both MTT (Figure
5a and b) and DNA quantitation assays using Hoechst dye
(Figure 5c-f). In selected growth assays, tocopherol was
included as anti-oxidant. Tocopherol (10ftM) had very
limited effects on the growth inhibited by fatty acids at high
concentrations (Figure 5c-f).
As the effects of fatty acids on cell attachment and motility
which were assayed after 30 min and 20 h at concentrations
lower than 100 ZM, the inhibition could not be attributed to
the effects on growth.
0 1 10 100 1000
AA (AM)
Figure 3 Inhibition of colon cancer cell (HT115) attachment to
extracellular matrix components by fatty acids. Both GLA and
LiGLA show concentration-dependent inhibition of attachment
to both Matrigel-coated (a) and fibronectin-coated (b) plates. LA
resulted in a weak inhibition and AA had no effect. Similar data
were also obtained with HT29 and HRT18 cells (mean ± s.e.m.,
n = 4).
Effects offatty acids on E-cadherin andfibronectin receptors
Culture of cells with n-6 fatty acids, particularly GLA,
resulted in an increased E-cadherin expression after 24 h
culture (Figure 6). Flow cytometry showed a small but
insignificant decrease in fibronectin receptor expression.
These changes were not seen in 30 and 60min cultures. In
order to determine the possible role of the E-cadherin, anti-
E-cadherin antibody (0.5jigml-') was added to the cells. The
antibody itself caused significant loosening of colonies, par-
ticularly with HT29 and HRT18 cells. (Figure 1). GLA
reduced colony scattering induced by HGF/SF, which was
completely prevented with the antibody (Figure le and f, k
and 1, for HT115 and HRT18 respectively).
To confirm E-cadherin expression on the cell surface,
immunohistochemical studies were performed. All three cells
had detectable E-cadherin on their surface, mainly on the
cell-cell margins. HRT18 and HT29 cells showed the
strongest staining (Figure 7). Cells, after 24 h culture with
GLA, exhibited more staining on the edge and cell-cell
junction areas. All these data indicate that the increased
cell-surface E-cadherin may be at least partly responsible for
the decreased scattering in the presence of GLA.
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Motility and invasiveness of cancer cells are key elements in
the establishing of metastasis. The possibility of anti-invasion
and anti-motility strategies may have important implications
for cancer management. In the past few years, various agents
have been shown to possess anti-invasion and anti-metastasis
properties; among these are Arg-Gly-Asp (RGD) sequence
peptides and motility-regulating factors (Miyake et al., 1991;
Mohler et al., 1992; Isoai et al., 1993). Although essential
fatty acids have previously been shown to inhibit cancer cell
growth after relatively prolonged incubation, the effect of
essential fatty acids on cancer cell motility and invasion have
not been previously reported.
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In this paper we report that short-term incubation with
certain n-6 fatty acids has pronounced anti-motility and anti-
invasion effects on some human colon cancer cell lines. Of
the acids tested, gamma-linolenic acid and its lithium salt had
the most profound effects; both linoleic and arachidonic acid
had only a slight effect. Unlike previous studies, the effects
reported here are dissociated from inhibition of cell growth.
The experimental conditions used here show specifically only
inhibition of motility and invasiveness. Our data show that
GLA inhibits both attachment to extracellular matrix com-
ponents (Matrigel and fibronectin) and invasion into Matri-
gel. The reduced attachment may be therefore partly respon-
sible for the diminished invasion because of the critical
importance of attachment of cells before invasion.
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Figure 5 Effects of fatty acids on tumour cell growth assayed by both MTT (a and b) and Hoechst 33258 (c-f). (a) HTI 15 cells
were cultured with fatty acids (-, GLA; A, LiGLA; V, LA; *, AA) for 72 h and cell growth quantified by MTT assay. GLA and
LiGLA at concentrations over 100 JM slightly inhibited growth. (b) Different cell lines (A, HRT18; V, HT29) were cultured with
GLA (100 jAM) for up to 6 days. No significant inhibition was seen (c-f). HT115 cells cultured with different fatty acid with (A) or
without (U) tocopherol (1O LM) for 72 h. DNA contents were quantified by Hoechst 33258 assay and are shown as fluorescence
units. GLA and LiGLA caused inhibition at higher concentrations (200ltM). LA and AA had no significant effects at the
concentration and over the period tested.
120
100
L-
CD
80
60
40
20
0
12 000
U)
.
C
, 10000
0
° 00 o 8000
0
0 .2 4000
- 2000
z
n
12 000
U) C
0
C._
c
0
U1)
0 c
0
-
o
z
0
10 000
8000
6000
4000
2000
0
I
I
I
F
I
I1 .... ... ....... ........ a
I
I
.
I
I ..... ... u L-
r f
F r
. x I:F I T
- I
l4*
I ...
I'
I. A . ......
L-- I I T
L x- -4
T
rTiInhibition of invasion and motility by GLA
WG Jiang etal
750
102
1oo
a
,i A4
0
c
1U
102
lo1
loo
b
200 400 600 800 1000
d
10"
lo3
1000
12
lo1
loo
200 400 600 800 1000
Figure 6 Effect of fatty acid on E-cadherin as measured by flow cytometry. HT29 (a and b) and HRT18 (c and d) were cultured
with medium as control (a and c) or GLA 501M (b and d) for 24 h. Cells were then stained with HECD-I antibody and
FITC-labelled secondary antibody. The fluorescence was then determined via flow cytometry. GLA induces increased expression of
E-cadherin in both cell types, which can be seen as brighter stained populations in b and d.
Figure 7 Immunohistochemical staining of E-cadherin by HECD-1 antibody. HRT18 (a and b) and HT29 (c and d) cells were
cultured with or without GLA for 24 h. All cells showed E-cadherin staining before treatment (a and c). The distribution of
E-cadherin was mostly along the cell margins and cell-cell junctions. GLA treatment (b and d) increased staining, particularly at
cell-cell junctions.
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Although the mechanisms of cell motility and invasion are
not clear, these processes probably require receptor binding,
intracellular signalling and modification of cytoskeleton and
cell-surface adhesion molecules. Expression of E-cadherin has
been shown to be inversely related to cancer metastasis and
invasiveness (Behrens et al., 1991; Schipper et al., 1991;
Shiozaki et al., 1991; Doki et al., 1993; Oka et al., 1993). The
loss of this molecule from the cell surface may allow cells to
become detached from one another and thus promote
tumour cell invasiveness. E-cadherin enables establishment of
intercellular junctions by reacting with other molecules on
adjacent cell surfaces. Our data also show that anti-E-
cadherin antibody may partially block cells from growing in
colonies. Inhibition of HGF/SF-induced colony scattering by
GLA can be prevented by anti-E-cadherin antibody. All this
evidence together with the demonstration ofincreased expres-
sion of E-cadherin after treatment with GLA may provide an
explanation for the inhibitory effects ofGLA on colon cancer
motility and invasion shown in this study.
It has been suggested that the effect of n-6 fatty acids on
cell growth is partly via their oxidative metabolites, partic-
ularly superoxide (Begin et al., 1988; Horrobin, 1990; Takeda
et al., 1992, 1993), although others disagree (Botha et al.,
1989). It is, however, unlikely that the effects of these fatty
acids on cancer cell invasion and motility, as reported here,
occur via oxidative products. The effect on cell attachment
was seen within 30 min of treatment, and inclusion of toco-
pherol has no effects on the inhibition seen with GLA,
suggesting that slowly appearing metabolites have little effect.
Further study will be required to establish firmly whether
these effects involve metabolites of GLA.
In summary, n-6 fatty acids, particularly gamma-linolenic
acid, possess anti-motility and anti-invasion properties. At
concentrations which do not affect cell growth of human
colon cancer cell lines, these essential fatty acids significantly
inhibit HGF/SF-induced motility and invasion of these cells
into an extracellular matrix. Although the underlying mech-
anism is not yet established, the increased E-cadherin expres-
sion on the cell surface induced by gamma-linolenic acid
provides a strong indication for the direction of further
investigation.
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